| scholarly article | Q13442814 |
| P2093 | author name string | Seong-Hoon Park | |
| Dong Kim | |||
| Chul Park | |||
| Chang-Hwan Seol | |||
| Do-Sim Park | |||
| Eun-Taik Jeong | |||
| Hak-Ryul Kim | |||
| Ki-Eun Hwang | |||
| Yu-Ri Hwang | |||
| Byoung-Ryun Kim | |||
| Kyung-Hwa Cho | |||
| P2860 | cites work | Inflammation and cancer | Q24649640 |
| C-reactive protein: a critical update | Q24672855 | ||
| Cancer-related inflammation | Q27860907 | ||
| Molecular basis of metastasis. | Q34304177 | ||
| The role of C-reactive protein as a prognostic indicator in advanced cancer | Q34590826 | ||
| Prognostic factors in non-small cell lung cancer: a decade of progress | Q34844271 | ||
| The usefulness of procalcitonin and C-reactive protein as early diagnostic markers of bacteremia in cancer patients with febrile neutropenia | Q35340924 | ||
| Evaluation of seven tumour markers in pleural fluid for the diagnosis of malignant effusions | Q36619898 | ||
| The systemic inflammatory response, weight loss, performance status and survival in patients with inoperable non-small cell lung cancer. | Q36623998 | ||
| Evaluation of cumulative prognostic scores based on the systemic inflammatory response in patients with inoperable non-small-cell lung cancer | Q36648454 | ||
| Role of tumor markers in patients with solid cancers: A critical review | Q36797943 | ||
| Diagnostic accuracy of tumour markers for malignant pleural effusion: a meta-analysis | Q36851036 | ||
| A systematic review of the association between circulating concentrations of C reactive protein and cancer | Q36910671 | ||
| Diagnostic utility of pleural fluid carcinoembryonic antigen and CYFRA 21-1 in patients with pleural effusion: a systematic review and meta-analysis. | Q37006185 | ||
| Malignant effusions: Diagnostic evaluation and therapeutic strategy | Q40124844 | ||
| C-reactive protein in simple community-acquired pneumonia | Q40499802 | ||
| Significance of preoperative elevation of serum C-reactive protein as an indicator for prognosis in colorectal cancer | Q44076023 | ||
| The IASLC Lung Cancer Staging Project: proposals for revision of the M descriptors in the forthcoming (seventh) edition of the TNM classification of lung cancer | Q45027131 | ||
| Validity of procalcitonin and C-reactive protein measurement when differentiating between benign and malignant pleural effusion | Q46710168 | ||
| Increased oxidative stress in exudative pleural effusions: a new marker for the differentiation between exudates and transudates? | Q46817054 | ||
| A simple C-reactive protein measurement for the differentiation between tuberculous and malignant pleural effusion | Q48015659 | ||
| Expression of C-reactive protein by renal cell carcinomas and unaffected surrounding renal tissue. | Q53653886 | ||
| Diagnostic utility of CYFRA 21-1, carcinoembryonic antigen, CA 125, neuron specific enolase, and squamous cell antigen level determinations in the serum and pleural fluid of patients with pleural effusions | Q59274557 | ||
| Serum C-Reactive Protein as Independent Prognostic Variable in Patients with Ovarian Cancer | Q61853683 | ||
| Use of pleural fluid C-reactive protein in laboratory diagnosis of pleural effusions | Q67874661 | ||
| Immunoreactive interleukin-6 and acute phase proteins as prognostic factors in multiple myeloma. Finnish Leukemia Group | Q71670365 | ||
| Diagnostic principles in pleural disease | Q73094101 | ||
| White blood cells, C-reactive protein and erythrocyte sedimentation rate in pneumococcal pneumonia in children | Q73367332 | ||
| Improving tumor cell detection in pleural effusions by interphase cytogenetics | Q73887318 | ||
| Use of pleural fluid C-reactive protein in diagnosis of pleural effusions | Q73928526 | ||
| The association between hospitalisation for pneumonia and the diagnosis of lung cancer | Q80225839 | ||
| Preoperative serum C-reactive protein level in non-small cell lung cancer | Q80789268 | ||
| The impact of preoperative serum C-reactive protein on the prognosis of patients with hepatocellular carcinoma | Q81547801 | ||
| Elevated preoperative C-reactive protein predicts poor cancer specific survival in patients undergoing resection for non-small cell lung cancer | Q84190105 | ||
| P275 | copyright license | Creative Commons Attribution-NonCommercial 3.0 Unported | Q18810331 |
| P6216 | copyright status | copyrighted | Q50423863 |
| P433 | issue | 2 | |
| P304 | page(s) | 396-402 | |
| P577 | publication date | 2013-03-01 | |
| P1433 | published in | Yonsei Medical Journal | Q8055114 |
| P1476 | title | Diagnostic value and prognostic significance of pleural C-reactive protein in lung cancer patients with malignant pleural effusions | |
| P478 | volume | 54 |
| Q39426966 | Management of malignant pleural effusion: challenges and solutions. |
| Q37652155 | Pleural fluid prealbumin and C-reactive protein in the differential diagnosis of infectious and malignant pleural effusions |
| Q90166775 | Preoperative serum C-reactive protein levels and postoperative survival in patients with esophageal squamous cell carcinoma: a propensity score matching analysis |
Search more.